JP2017508782A5 - - Google Patents

Download PDF

Info

Publication number
JP2017508782A5
JP2017508782A5 JP2016562464A JP2016562464A JP2017508782A5 JP 2017508782 A5 JP2017508782 A5 JP 2017508782A5 JP 2016562464 A JP2016562464 A JP 2016562464A JP 2016562464 A JP2016562464 A JP 2016562464A JP 2017508782 A5 JP2017508782 A5 JP 2017508782A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
membered
carbon atoms
independently hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562464A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017508782A (ja
JP6574444B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/010085 external-priority patent/WO2015103508A1/en
Publication of JP2017508782A publication Critical patent/JP2017508782A/ja
Publication of JP2017508782A5 publication Critical patent/JP2017508782A5/ja
Application granted granted Critical
Publication of JP6574444B2 publication Critical patent/JP6574444B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562464A 2014-01-06 2015-01-05 炭素環式スルホンRORγ調節因子 Expired - Fee Related JP6574444B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461923911P 2014-01-06 2014-01-06
US61/923,911 2014-01-06
PCT/US2015/010085 WO2015103508A1 (en) 2014-01-06 2015-01-05 CARBOCYCLIC SULFONE RORγ MODULATORS

Publications (3)

Publication Number Publication Date
JP2017508782A JP2017508782A (ja) 2017-03-30
JP2017508782A5 true JP2017508782A5 (enExample) 2018-01-25
JP6574444B2 JP6574444B2 (ja) 2019-09-11

Family

ID=52392246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562464A Expired - Fee Related JP6574444B2 (ja) 2014-01-06 2015-01-05 炭素環式スルホンRORγ調節因子

Country Status (6)

Country Link
US (1) US9771320B2 (enExample)
EP (1) EP3092216B1 (enExample)
JP (1) JP6574444B2 (enExample)
CN (1) CN106132931B (enExample)
ES (1) ES2713681T3 (enExample)
WO (1) WO2015103508A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3044219A1 (en) 2013-09-09 2016-07-20 Bristol-Myers Squibb Company Rorgamma modulators
EP3046906B1 (en) 2013-09-20 2017-08-16 Bristol-Myers Squibb Company Ror gamma modulators
US9771320B2 (en) 2014-01-06 2017-09-26 Bristol-Myers Squibb Company Carbocyclic sulfone RORγ modulators
EP3092221B1 (en) 2014-01-06 2018-10-17 Bristol-Myers Squibb Company Heterocyclic sulfones as ror-gamma modulators
WO2015103509A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
ES2704460T3 (es) * 2014-01-06 2019-03-18 Bristol Myers Squibb Co Moduladores de ROR gamma de ciclohexilsulfona
LT3212641T (lt) 2014-10-30 2019-02-11 Janssen Pharmaceutica Nv Tiazolai, kaip roryt moduliatoriai
JOP20200117A1 (ar) 2014-10-30 2017-06-16 Janssen Pharmaceutica Nv كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t
US9845319B2 (en) 2014-10-30 2017-12-19 Janssen Pharmaceutiuca NV Amide substituted thiazoles as modulators of RORyt
WO2016179460A1 (en) 2015-05-07 2016-11-10 Bristol-Myers Squibb Company Tricyclic sulfones as rorϒ modulators
TWI691486B (zh) * 2016-01-29 2020-04-21 日商東麗股份有限公司 環狀胺衍生物及其醫藥用途
EP3438109B1 (en) * 2016-03-31 2021-08-25 Takeda Pharmaceutical Company Limited Heterocyclic compound
TW201803869A (zh) 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
MX2019005384A (es) * 2016-11-09 2019-08-12 Squibb Bristol Myers Co Sulfonas triciclicas como moduladores del receptor huerfano relacionado con retinoide (ror) gamma.
CN110913859A (zh) * 2017-07-27 2020-03-24 东丽株式会社 圆形脱毛症的治疗剂或预防剂
WO2019022234A1 (ja) * 2017-07-27 2019-01-31 東レ株式会社 炎症性腸疾患の治療剤又は予防剤
CN112292373A (zh) 2018-06-18 2021-01-29 詹森药业有限公司 作为RORγt的调节剂的吡啶基吡唑类
EP3806958B1 (en) 2018-06-18 2022-09-07 Janssen Pharmaceutica NV 6-aminopyridin-3-yl pyrazoles as modulators of roryt
EP3790865A1 (en) 2018-06-18 2021-03-17 Janssen Pharmaceutica NV Phenyl substituted pyrazoles as modulators of roryt
ES2929140T3 (es) 2018-06-18 2022-11-25 Janssen Pharmaceutica Nv Imidazoles sustituidos con fenilo y piridinilo como moduladores de RORgammat
WO2020231713A1 (en) * 2019-05-13 2020-11-19 Bristol-Myers Squibb Company AGONISTS OF ROR GAMMAt

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639903A1 (de) 1986-11-22 1988-06-01 Bayer Ag Saccharin-salze von aminomethylheterocyclen
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
CN100562516C (zh) * 2001-12-27 2009-11-25 第一制药株式会社 β-淀粉样蛋白产生和分泌的抑制剂
GB0513747D0 (en) * 2005-07-06 2005-08-10 Merck Sharp & Dohme Therapeutic compounds
JP4955566B2 (ja) * 2005-10-19 2012-06-20 キッセイ薬品工業株式会社 縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途
US9216988B2 (en) * 2011-12-22 2015-12-22 Genentech, Inc. Benzyl sulfonamide derivatives as RORc modulators
US20130190356A1 (en) * 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
IN2014DN08025A (enExample) 2012-05-08 2015-05-01 Merck Sharp & Dohme
MX367341B (es) * 2012-05-08 2019-08-14 Merck Sharp & Dohme Tetrahidronaftiridina y compuestos biciclicos relacionados para la inhibicion de la actividad de rorgamma y el tratamiento de enfermedades.
WO2014028691A1 (en) * 2012-08-15 2014-02-20 Interdigital Patent Holdings, Inc. Enhancements to enable fast security setup
WO2014028669A1 (en) 2012-08-15 2014-02-20 Biogen Idec Ma Inc. Novel compounds for modulation of ror-gamma activity
WO2014062938A1 (en) 2012-10-19 2014-04-24 Bristol-Myers Squibb Company Rory modulators
EP3044219A1 (en) 2013-09-09 2016-07-20 Bristol-Myers Squibb Company Rorgamma modulators
EP3046906B1 (en) 2013-09-20 2017-08-16 Bristol-Myers Squibb Company Ror gamma modulators
WO2015103509A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
US9771320B2 (en) 2014-01-06 2017-09-26 Bristol-Myers Squibb Company Carbocyclic sulfone RORγ modulators
ES2704460T3 (es) 2014-01-06 2019-03-18 Bristol Myers Squibb Co Moduladores de ROR gamma de ciclohexilsulfona
EP3092221B1 (en) 2014-01-06 2018-10-17 Bristol-Myers Squibb Company Heterocyclic sulfones as ror-gamma modulators

Similar Documents

Publication Publication Date Title
JP2017508782A5 (enExample)
JP2017501237A5 (enExample)
JP2017509689A5 (enExample)
JP2016514159A5 (enExample)
JP2019501125A5 (enExample)
JP2013537203A5 (enExample)
JP2018522879A5 (enExample)
JP2016503799A5 (enExample)
JP2013509431A5 (enExample)
JP2016505637A5 (enExample)
JP2018516238A5 (enExample)
JP2019524883A5 (enExample)
JP2016516043A5 (enExample)
JP2016501221A5 (enExample)
JP2015517574A5 (enExample)
JP2016523974A5 (enExample)
JP2016506960A5 (enExample)
JP2020502092A5 (enExample)
JP2016530283A5 (enExample)
JP2013512903A5 (enExample)
JP2017528498A5 (enExample)
JP2016505614A5 (enExample)
JP2016506369A5 (enExample)
JP2016532715A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии